TW202527939A - 單一的軸向不對稱化合物之選擇性製造方法 - Google Patents
單一的軸向不對稱化合物之選擇性製造方法Info
- Publication number
- TW202527939A TW202527939A TW113133938A TW113133938A TW202527939A TW 202527939 A TW202527939 A TW 202527939A TW 113133938 A TW113133938 A TW 113133938A TW 113133938 A TW113133938 A TW 113133938A TW 202527939 A TW202527939 A TW 202527939A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- group
- salt
- following
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/JP2023/032816 | 2023-09-08 | ||
| PCT/JP2023/032816 WO2025052649A1 (ja) | 2023-09-08 | 2023-09-08 | 単一の軸不斉化合物の選択的製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202527939A true TW202527939A (zh) | 2025-07-16 |
Family
ID=94923286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW113133938A TW202527939A (zh) | 2023-09-08 | 2024-09-06 | 單一的軸向不對稱化合物之選擇性製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP7700399B1 (https=) |
| CN (1) | CN121843933A (https=) |
| AU (1) | AU2024337896A1 (https=) |
| CO (1) | CO2026004110A2 (https=) |
| MX (1) | MX2026002723A (https=) |
| TW (1) | TW202527939A (https=) |
| WO (2) | WO2025052649A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190186A1 (ar) * | 2017-02-02 | 2019-08-01 | Astellas Pharma Inc | مركب كينازولين |
| WO2022173032A1 (ja) * | 2021-02-15 | 2022-08-18 | アステラス製薬株式会社 | Ｇ１２ｄ変異ｋｒａｓタンパクの分解を誘導するためのキナゾリン化合物 |
| EP4293025B1 (en) * | 2021-02-15 | 2025-10-29 | Astellas Pharma Inc. | 4-aminoquinazoline compound |
| TW202346270A (zh) * | 2022-03-11 | 2023-12-01 | 日商安斯泰來製藥股份有限公司 | 用於誘發g12d突變kras蛋白分解之雜環化合物 |
| US20250145631A1 (en) * | 2022-07-21 | 2025-05-08 | Astellas Pharma Inc. | Heterocyclic compound acting on g12d mutant kras protein |
| TW202412789A (zh) * | 2022-08-05 | 2024-04-01 | 日商安斯泰來製藥股份有限公司 | 用於誘導突變kras蛋白分解之雜環化合物 |
| EP4570794A1 (en) * | 2022-08-09 | 2025-06-18 | Astellas Pharma, Inc. | Heterocyclic compound for inhibiting and/or inducing degradation of kras protein |
| EP4570795A1 (en) * | 2022-08-09 | 2025-06-18 | Astellas Pharma, Inc. | Heterocyclic compound for inducing degradation of g12v mutant kras protein |
-
2023
- 2023-09-08 WO PCT/JP2023/032816 patent/WO2025052649A1/ja active Pending
-
2024
- 2024-09-06 AU AU2024337896A patent/AU2024337896A1/en active Pending
- 2024-09-06 TW TW113133938A patent/TW202527939A/zh unknown
- 2024-09-06 CN CN202480055263.4A patent/CN121843933A/zh active Pending
- 2024-09-06 JP JP2025523047A patent/JP7700399B1/ja active Active
- 2024-09-06 WO PCT/JP2024/031959 patent/WO2025053242A1/ja active Pending
-
2026
- 2026-03-06 MX MX2026002723A patent/MX2026002723A/es unknown
- 2026-03-30 CO CONC2026/0004110A patent/CO2026004110A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2026002723A (es) | 2026-04-01 |
| JP7700399B1 (ja) | 2025-06-30 |
| WO2025052649A1 (ja) | 2025-03-13 |
| WO2025053242A1 (ja) | 2025-03-13 |
| CO2026004110A2 (es) | 2026-04-16 |
| AU2024337896A1 (en) | 2026-03-19 |
| JPWO2025053242A1 (https=) | 2025-03-13 |
| CN121843933A (zh) | 2026-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7398436B2 (ja) | メチル６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アンヌレン－２－カルボキシレートの塩およびその製造方法 | |
| JP5604424B2 (ja) | アポトーシス促進剤ａｂｔ−２６３の調製のための方法 | |
| CN114929706A (zh) | Kras g12c的抑制剂 | |
| JP2022520047A (ja) | 鏡像異性的に濃縮されたｊａｋ阻害剤を調製するための方法 | |
| TWI750685B (zh) | 二取代吡唑化合物 | |
| CN110041333B (zh) | 溴结构域抑制剂化合物及其用途 | |
| US12077528B2 (en) | Preparation method for deuterated macrocyclic compound | |
| CN113039178A (zh) | 吡啶并[2,3-d]嘧啶-7(8H)-酮的合成 | |
| KR20050104376A (ko) | 고리형상 벤즈아미딘 유도체의 제조방법 | |
| AU2023216654B2 (en) | Processes for the preparation of selective estrogen receptor degraders | |
| JPWO2016121777A1 (ja) | ピラジンカルボキサミド化合物の製造方法及びその合成中間体 | |
| EP2914582A2 (en) | Chiral fluorinating reagents | |
| CN117677616A (zh) | 制备血红蛋白调节剂的方法 | |
| CN116888109A (zh) | 作为Wee-1抑制剂的嘧啶化合物 | |
| JP7700399B1 (ja) | 単一の軸不斉化合物の選択的製造法 | |
| CN107531680A (zh) | 一种新毒素及其中间体的制备方法 | |
| JP2025510230A (ja) | Ｓｈｐ２阻害剤の調製プロセス | |
| CN121443603A (zh) | 能够用于治疗smarca4缺失型癌症的作为smarca2抑制剂的1,6-萘啶化合物 | |
| JP2017081832A (ja) | トリアジンジオン化合物 | |
| JP2003221394A (ja) | キヌクリジン誘導体の製造方法 | |
| BR122025017416A2 (pt) | Compostos degradadores seletivos de receptores de estrogênio | |
| BR112024013443B1 (pt) | Processos para a preparação de degradadores seletivos de receptores de estrogênio | |
| BR122025017409A2 (pt) | Compostos degradadores seletivos de receptores de estrogênio | |
| JPWO2017038870A1 (ja) | 尿素誘導体及びその用途 | |
| CA3214107A1 (en) | New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds |